TRELLUS HEALTH PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.75 GBX | 0.00% |
|
-12.50% | -46.15% |
| Feb. 28 | Trellus Health Signs Agreement for Bowel Disease Management in the US | MT |
| Feb. 28 | Trellus Health plc Announces Christopher Mills Will Step Down as Non-Executive Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Trellus Health plc is a United Kingdom-based digital health company. It offers a scientifically validated, personalized resilience-based self-management training program for people living with chronic conditions. It is focused on the intersection of chronic physical conditions and mental health. The Company's approach transforms chronic disease management and changes the lives of patients living with debilitating, incurable conditions, primarily focused on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, and irritable bowel syndrome (IBS). The TrellusElevate platform is the Company's connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Through its TrellusElevate connected care platform and companion App, the Company addresses both clinical and behavioral health together. The Company's wholly owned subsidiary is Trellus Health Inc.
Sector
Software
Calendar
2024-04-22
- Q4 2023 Earnings Release
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -46.15% | 3.52M | |
| +7.52% | 3,004B | |
| +0.93% | 79.28B | |
| +4.97% | 77.94B | |
| -13.96% | 53.9B | |
| -18.60% | 50.22B | |
| +23.06% | 46.76B | |
| +12.30% | 39.49B | |
| +39.01% | 31.91B | |
| -12.62% | 23.99B |
- Stock Market
- Equities
- TRLS Stock
- News Trellus Health plc
- Trellus Health : Earnings Flash (TRLS.L) TRELLUS HEALTH Reports H1 Loss $-0.01
